Reports of Adverse Events Associated with Use of Novel Psychoactive Substances, 2013–2016: A Review
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Novel psychoactive substances (NPS) represent significant analytical and interpretive challenges to forensic and clinical toxicologists. Timely access to case reports and reports of adverse incidents of impairment or toxicity is imperative to clinical diagnosis and treatment, as well as to interpretation of forensic results. Delays in identifying the presence of a novel intoxicating agent have significant consequences for public health and public safety. Adverse effects of intoxications with novel cannabinoids, stimulants, hallucinogens, benzodiazepines and opioids spanning January 2013 through December 2016 as reported in emergency departments, death investigations, impaired driving cases and other forensic contexts are the subject of this review. Discussion of the chemistry, pharmacology and adverse events associated with novel drug classes is summarized and described within. Adverse effects or symptoms associated with ingestion of more than 45 NPS have been abstracted and summarized in tables, including demographics, case history, clinical or behavioral symptoms, autopsy findings and drug confirmations with quantitative results when provided. Based on these findings and gaps in the available data, we provide recommendations for future toxicological testing of these evolving substances. These include development and management of a national monitoring program to provide real-time clinical and toxicological data, confirmed analytically, on emerging drugs and their known toxidromes and side effect profiles. Increased efforts should be made to analytically confirm the agents responsible for clinical intoxications involving adverse events in emergency department admissions or hospitalizations. Evidence-based community preparedness among analytical laboratories gained through active communication and sharing of toxicological findings and trends in NPS is imperative to assist in enabling early detection of new drugs in forensic and clinical populations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Increases in drug and opioid overdose deaths — United States, 2000–2014
Rudd, R. A., Aleshire, N., Zibbell, J. E., & Gladden, R. M. (2016) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6450a3 · Cited by 1,859
Nichols, D. E. (2016) · Pharmacological Reviews · doi:10.1124/pr.115.011478 · Cited by 1,762
Novel psychoactive substances of interest for psychiatry
Schifano, F., Orsolini, L., Duccio Papanti, G., & Corkery, J. M. (2015) · World Psychiatry · doi:10.1002/wps.20174 · Cited by 321
Cited by
Serotonin Syndrome: Pathophysiology, Clinical Features, Management, and Potential Future Directions
Scotton, W. J., Hill, L. J., Williams, A. C., & Barnes, N. M. (2019) · International Journal of Tryptophan Research · doi:10.1177/1178646919873925 · Cited by 267
Logan, B. K., D’Orazio, A. L., Mohr, A. L. A., Limoges, J. F., Miles, A. K., Scarneo, C. E., Kerrigan, S., Liddicoat, L. J., Scott, K. S., & Huestis, M. A. (2018) · Journal of Analytical Toxicology · doi:10.1093/jat/bkx082 · Cited by 78
“These include compounds such as the synthetic cannabinoids, cathinones and “bath salts”, and novel opioids, especially analogs (4, 5).”
BackgroundSelf-citationD’Orazio, A. L., Mohr, A. L. A., Chan-Hosokawa, A., Harper, C., Huestis, M. A., Limoges, J. F., Miles, A. K., Scarneo, C. E., Kerrigan, S., Liddicoat, L. J., et al. (2021) · Journal of Analytical Toxicology · doi:10.1093/jat/bkab064 · Cited by 60
“NPSs include synthetic cannabinoids, cathinones and “bath salts”, and novel opioids, especially fentanyl analogs (4, 5).”
BackgroundSelf-citationZhu, Y., Stephenson, C., Moghimi, E., Jagayat, J., Nikjoo, N., Kumar, A., Shirazi, A., Patel, C., Omrani, M., & Alavi, N. (2023) · PLOS ONE · doi:10.1371/journal.pone.0285757 · Cited by 7
“However, dependence, tolerance, abuse potential, and adverse effects (e.g., memory impairment, irritability, and confusion) are commonly reported side effects [7,8].”
Metadata
- Authors
- Logan, B. K., Mohr, A. L. A., Friscia, M., Krotulski, A. J., Papsun, D. M., Kacinko, S. L., Ropero-Miller, J. D., & Huestis, M. A.
- Venue
- Journal of Analytical Toxicology
- Publisher
- Oxford University Press (OUP)
- Published
- 2017-04-28
- Volume
- 41
- Issue
- 7
- Pages
- 573-610
- ISSN
- 0146-4760 (ISSN-L)
- 1945-2403
- OpenAlex
- W2608262290
- Cited by
- 166
- References
- 3
- FWCI
- 46.45
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Reports of Adverse Events Associated with Use of Novel Psychoactive Substances, 2013–2016: A Review. https://app.cochat.ai/papers/10.1093/jat/bkx031
- The paper
- Logan, B. K., Mohr, A. L. A., Friscia, M., Krotulski, A. J., Papsun, D. M., Kacinko, S. L., Ropero-Miller, J. D., & Huestis, M. A. (2017). Reports of Adverse Events Associated with Use of Novel Psychoactive Substances, 2013–2016: A Review. Journal of Analytical Toxicology. https://doi.org/10.1093/jat/bkx031
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.